Pillstats
Rx only · Injection, Solution · Subcutaneous

Dulaglutide

Brands: Trulicity · Dulaglutide

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US11 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)1551291
US makers2 labelers
Packages15
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$140.21$280.42$420.62$560.83Dec 2025May 2026Jul 2026
$487.506
Latest avg · Jul 22, 2026
+2%
Since Dec 17, 2025
2
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

286K572K859K1.1M2025 Q12025 Q22025 Q32025 Q42026 Q1
767K
Rx · 2026 Q1
1.6M
Units dispensed
-23%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Eli Lilly and Companyunknown8SUPPLYING
A-S Medication Solutionsunknown7SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Apr 5, 2022
    RECALLRecall (Class II): Trulicity (dulaglutide) injection, 0.75 mg/0.5mL once weekly, 4 Single-Dose Pens, Rx only, Eli Lilly and Company, Indi…

    TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions — Recalling firm: Cardinal Health Inc. — NM only

  • Aug 19, 2021
    RECALLRecall (Class II): Trulicity (dulaglutide), 0.75 mg/0.5 mL, 4 Single-Dose Pens per box, Rx only, Eli Lilly and Company, Indianapolis, IN 4…

    Labeling: Label error on declared strength - autoinjector devices labeled as 0.75 mg / 0.5 mL actually contain 1.5 mg / 0.5 mL of product. — Recalling firm: Eli Lilly & Company — USA Nationwide